Product analysis
Twice Daily Multi brings together nutrients that support normal skin and eye function, particularly when dietary intake is low. Undisclosed proportions in its vitamin blends make the exact mix harder to compare.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality42
The natural vitamin E forms and the boron form are favorable features. Quality across the other nutrients remains uncertain, so these strengths do not establish the quality of the entire mix.
Ingredient Transparency79
Amounts and nearly all forms are stated, which helps with checking the label. The proportions within the vitamin A and vitamin E mixtures are not disclosed.
Value For Money39
The vitamin A and boron contributions are relatively costly, while the vitamin E offers limited value. Value for most of the other nutrients cannot be judged reliably.
Customer Satisfaction69
The available ratings are highly positive. The small number of responses leaves a less settled picture of customer satisfaction.
Product Focus48
The clearest nutritional fit is support for normal skin and eye function. The broad formula does not establish extra cosmetic benefits or improved vision in someone whose intake is already adequate.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $1.04
- Customer rating
- 4.7 · 41 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin A (Mixed Carotenoids, Vitamin A Palmitate) | 3200 IU | |
Vitamin C (Ascorbic Acid) | 500 mg | |
Vitamin D (Cholecalciferol) | 500 IU | |
Vitamin E (D-Alpha-Tocopherol) | 24 IU | |
Thiamine (Thiamine Hydrochloride) | 50 mg | |
Riboflavin | 30 mg | |
Niacin (Niacinamide) | 30 mg | |
Vitamin B6 (Pyridoxine Hydrochloride) | 50 mg | |
NatureFolate Blend | 400 mcg | |
Vitamin B12 (Methylcobalamin) | 500 mcg | |
Biotin (D-Biotin) | 300 mcg | |
Pantothenic Acid (D-Calcium Pantothenate) | 50 mg | |
Iodine (Potassium Iodide) | 75 mcg | |
Zinc (TRAACS Zinc Glycinate Chelate) | 15 mg | |
Selenium (Selenium Glycinate) | 200 mcg | |
Manganese (TRAACS Manganese Glycinate Chelate) | 3 mg | |
Chromium (TRAACS Chromium Nicotinate Glycinate Chelate) | 400 mcg | |
Molybdenum (TRAACS Molybdenum Glycinate Chelate) | 100 mcg | |
Mixed Tocopherols (D-Alpha-Tocopherol, D-Beta-Tocopherol, D-Delta-Tocopherol, D-Gamma-Tocopherol) | 158 mg | |
Alpha Lipoic Acid | 20 mg | |
Boron (Bororganic Glycine) | 2 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability77
Natural (d-alpha) vs. Synthetic (dl-alpha)
Mixed Tocopherol Isomer Diversity
Tocotrienol Complex Inclusion
Dose, Safety & Label Transparency48
Therapeutic Dosage Range
Label Transparency and Isomer Specificity
Value40
Cost per Natural-Form Therapeutic Serving
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Boron Form & Bioavailability
Trademarked & High-Purity Sources
Dose, Safety & Label Transparency80
Elemental Dose Transparency
Dosage Efficacy & Safety Margin
Value10
Price per 3mg Elemental Boron
How this ingredient is rated
Active Ingredient Quality & Bioavailability65
Vitamin A Chemical Form & Source
Dose, Safety & Label Transparency82
Dosage Efficacy & Safety Thresholds
Label Transparency of Specific Forms
Value20
Price per 5,000 IU Dose
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- U.S. Multicenter Clinical Trial of Corneal Collagen Crosslinking for Treatment of Corneal Ectasia after Refractive Surgery.
- United States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment.
- EpiSmart Crosslinking for Keratoconus: A Phase 2 Study.
- Prospective Randomized Trial of Corneal Cross-linking Riboflavin Dosing Frequencies for Treatment of Keratoconus and Corneal Ectasia.
- Corneal collagen cross-linking for keratoconus: results of 3-year follow-up in Pakistani population.
- Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial.
- The efficacy and safety of selenium supplementation versus placebo in the treatment of Graves' orbitopathy: A systematic review and meta-analysis of randomised controlled trials.
- Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction over six months of treatment: A Phase 2, vehicle-controlled, randomized extension trial.
- AZR-MD-001 0.5% selenium sulfide ophthalmic ointment for the treatment of contact lens discomfort: A vehicle-controlled, randomized, clinical trial.
- The effect of a biweekly novel selenium sulfide-containing topical treatment in symptomatic contact lens wearers: An exploratory study.
- A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
- Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial.
- Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.
- Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity.
- Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy.
- Role of Oral Vitamin 'C' on Astigmatic Errors in Phacoemulsification.
- Ascorbic acid metabolites are involved in intraocular pressure control in the general population.
- Nutritional modulation of cataract.
- Dietary n-3 Fatty Acid, α-Tocopherol, Zinc, vitamin D, vitamin C, and β-carotene are Associated with Age-Related Macular Degeneration in Japan.
- Adherence to a Mediterranean diet, lifestyle and age-related macular degeneration: the Coimbra Eye Study - report 3.